Lamont B Koo
Examiner (ID: 8622, Phone: (571)272-0984 , Office: P/2823 )
Most Active Art Unit | 2813 |
Art Unit(s) | 2813, 2823 |
Total Applications | 538 |
Issued Applications | 377 |
Pending Applications | 55 |
Abandoned Applications | 106 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 690337
[patent_doc_number] => 07074614
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-11
[patent_title] => 'Clock gene BMAL2'
[patent_app_type] => utility
[patent_app_number] => 10/467721
[patent_app_country] => US
[patent_app_date] => 2001-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 18
[patent_no_of_words] => 15078
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/074/07074614.pdf
[firstpage_image] =>[orig_patent_app_number] => 10467721
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/467721 | Clock gene BMAL2 | Aug 22, 2001 | Issued |
Array
(
[id] => 7170398
[patent_doc_number] => 20040077837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Microtubule-associated proteins and tubulins'
[patent_app_type] => new
[patent_app_number] => 10/362247
[patent_app_country] => US
[patent_app_date] => 2003-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37110
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077837.pdf
[firstpage_image] =>[orig_patent_app_number] => 10362247
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/362247 | Microtubule-associated proteins and tubulins | Aug 19, 2001 | Issued |
Array
(
[id] => 6394504
[patent_doc_number] => 20020036154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Solid pharmaceutical dosage formulation of hydrophobic drugs'
[patent_app_type] => new
[patent_app_number] => 09/925348
[patent_app_country] => US
[patent_app_date] => 2001-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4212
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20020036154.pdf
[firstpage_image] =>[orig_patent_app_number] => 09925348
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/925348 | Solid pharmaceutical dosage formulation of hydrophobic drugs | Aug 8, 2001 | Abandoned |
Array
(
[id] => 1092534
[patent_doc_number] => 06824991
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-30
[patent_title] => 'Human bad polypeptides, encoding nucleic acids and methods of use'
[patent_app_type] => B2
[patent_app_number] => 09/922378
[patent_app_country] => US
[patent_app_date] => 2001-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8989
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/824/06824991.pdf
[firstpage_image] =>[orig_patent_app_number] => 09922378
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/922378 | Human bad polypeptides, encoding nucleic acids and methods of use | Aug 2, 2001 | Issued |
Array
(
[id] => 1071951
[patent_doc_number] => 06841535
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-11
[patent_title] => 'Peptide-mediated transfection agents and methods of use'
[patent_app_type] => utility
[patent_app_number] => 09/915914
[patent_app_country] => US
[patent_app_date] => 2001-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 22
[patent_no_of_words] => 33375
[patent_no_of_claims] => 119
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/841/06841535.pdf
[firstpage_image] =>[orig_patent_app_number] => 09915914
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/915914 | Peptide-mediated transfection agents and methods of use | Jul 25, 2001 | Issued |
Array
(
[id] => 7361640
[patent_doc_number] => 20040014654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Method for treating unstable angina pectoris'
[patent_app_type] => new
[patent_app_number] => 10/333212
[patent_app_country] => US
[patent_app_date] => 2003-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3941
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014654.pdf
[firstpage_image] =>[orig_patent_app_number] => 10333212
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/333212 | Method for treating unstable angina pectoris | Jul 19, 2001 | Issued |
Array
(
[id] => 6361199
[patent_doc_number] => 20020058621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'Method for induced lactation'
[patent_app_type] => new
[patent_app_number] => 09/910473
[patent_app_country] => US
[patent_app_date] => 2001-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5605
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058621.pdf
[firstpage_image] =>[orig_patent_app_number] => 09910473
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/910473 | Method for induced lactation | Jul 19, 2001 | Issued |
Array
(
[id] => 1037556
[patent_doc_number] => 06872705
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-29
[patent_title] => 'Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions'
[patent_app_type] => utility
[patent_app_number] => 09/904753
[patent_app_country] => US
[patent_app_date] => 2001-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5823
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/872/06872705.pdf
[firstpage_image] =>[orig_patent_app_number] => 09904753
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/904753 | Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions | Jul 12, 2001 | Issued |
Array
(
[id] => 5936604
[patent_doc_number] => 20020061852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Methods of therapy with thrombin derived peptides'
[patent_app_type] => new
[patent_app_number] => 09/904090
[patent_app_country] => US
[patent_app_date] => 2001-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5353
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061852.pdf
[firstpage_image] =>[orig_patent_app_number] => 09904090
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/904090 | Methods of therapy with thrombin derived peptides | Jul 11, 2001 | Issued |
Array
(
[id] => 1086074
[patent_doc_number] => 06831151
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-12-14
[patent_title] => 'Mast cell-specific signal transducing molecules and cDNAs thereof'
[patent_app_type] => B1
[patent_app_number] => 09/856061
[patent_app_country] => US
[patent_app_date] => 2001-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 6432
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/831/06831151.pdf
[firstpage_image] =>[orig_patent_app_number] => 09856061
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/856061 | Mast cell-specific signal transducing molecules and cDNAs thereof | Jul 9, 2001 | Issued |
09/786797 | Human cytoskeleton associated proteins | Jun 24, 2001 | Abandoned |
Array
(
[id] => 7607403
[patent_doc_number] => 07098313
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-29
[patent_title] => 'DNA sequences coding for a polyol carrier and their use, in particular for the preparation of transgenic plants'
[patent_app_type] => utility
[patent_app_number] => 10/332815
[patent_app_country] => US
[patent_app_date] => 2001-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9151
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/098/07098313.pdf
[firstpage_image] =>[orig_patent_app_number] => 10332815
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/332815 | DNA sequences coding for a polyol carrier and their use, in particular for the preparation of transgenic plants | Jun 21, 2001 | Issued |
Array
(
[id] => 6801576
[patent_doc_number] => 20030096741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Enhanced mineral delivery'
[patent_app_type] => new
[patent_app_number] => 09/885593
[patent_app_country] => US
[patent_app_date] => 2001-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4286
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20030096741.pdf
[firstpage_image] =>[orig_patent_app_number] => 09885593
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/885593 | Enhanced mineral delivery | Jun 18, 2001 | Abandoned |
Array
(
[id] => 1080944
[patent_doc_number] => 06835813
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-12-28
[patent_title] => 'Testis-specific differentiation-regulatory factor'
[patent_app_type] => B1
[patent_app_number] => 09/743237
[patent_app_country] => US
[patent_app_date] => 2001-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10080
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/835/06835813.pdf
[firstpage_image] =>[orig_patent_app_number] => 09743237
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/743237 | Testis-specific differentiation-regulatory factor | Jun 3, 2001 | Issued |
Array
(
[id] => 1115463
[patent_doc_number] => 06800492
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-10-05
[patent_title] => 'Chimeric GFP-aequorin as bioluminescent Ca reporters at the single cell level'
[patent_app_type] => B2
[patent_app_number] => 09/863901
[patent_app_country] => US
[patent_app_date] => 2001-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 18
[patent_no_of_words] => 24901
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/800/06800492.pdf
[firstpage_image] =>[orig_patent_app_number] => 09863901
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/863901 | Chimeric GFP-aequorin as bioluminescent Ca reporters at the single cell level | May 23, 2001 | Issued |
09/763919 | Pharmaceutical compositions comprising factor xillla | May 20, 2001 | Abandoned |
Array
(
[id] => 6559497
[patent_doc_number] => 20020164640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'MyD88 adapter-like proteins'
[patent_app_type] => new
[patent_app_number] => 09/860696
[patent_app_country] => US
[patent_app_date] => 2001-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15602
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20020164640.pdf
[firstpage_image] =>[orig_patent_app_number] => 09860696
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/860696 | MyD88 adapter-like proteins | May 16, 2001 | Issued |
09/701787 | Peptides having nuclear transport activity | May 10, 2001 | Abandoned |
Array
(
[id] => 6638958
[patent_doc_number] => 20030211993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Method for promoting neovascularization'
[patent_app_type] => new
[patent_app_number] => 10/275997
[patent_app_country] => US
[patent_app_date] => 2002-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10877
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211993.pdf
[firstpage_image] =>[orig_patent_app_number] => 10275997
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/275997 | Method for promoting neovascularization | May 6, 2001 | Issued |
Array
(
[id] => 1024736
[patent_doc_number] => 06884778
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-04-26
[patent_title] => 'Biocompatible macromers'
[patent_app_type] => utility
[patent_app_number] => 09/845570
[patent_app_country] => US
[patent_app_date] => 2001-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8877
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/884/06884778.pdf
[firstpage_image] =>[orig_patent_app_number] => 09845570
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/845570 | Biocompatible macromers | Apr 29, 2001 | Issued |